Literature DB >> 19375465

Involvement of oxidative pathways in cytokine-induced secretory phospholipase A2-IIA in astrocytes.

Michael D Jensen1, Wenwen Sheng, Agnes Simonyi, Gary S Johnson, Albert Y Sun, Grace Y Sun.   

Abstract

Recent studies have suggested the involvement of secretory phospholipase A2-IIA (sPLA2-IIA) in neuroinflammatory diseases. Although sPLA2-IIA is transcriptionally induced through the NF-kappaB pathway by pro-inflammatory cytokines, whether this induction pathway is affected by other intracellular signaling pathways has not been investigated in detail. In this study, we demonstrated the induction of sPLA2-IIA mRNA and protein expression in astrocytes by cytokines and detected the protein in the culture medium after stimulation. We further investigated the effects of oxidative pathways and botanical antioxidants on the induction pathway and observed that IL-1beta-induced sPLA2-IIA mRNA expression in astrocytes is dependent on ERK1/2 and PI-3 kinase, but not p38 MAPK. In addition to apocynin, a known NADPH oxidase inhibitor, botanical antioxidants, such as resveratrol and epigallocatechin gallate, also inhibited IL-1beta-induced sPLA2-IIA mRNA expression. These compounds also suppressed IL-1beta-induced ERK1/2 activation and translocation of the NADPH oxidase subunit p67 phox from cytosol to membrane fraction. Taken together, these results support the involvement of reactive oxygen species from NADPH oxidase in cytokine induction of sPLA2-IIA in astrocytes and promote the use of botanical antioxidants as protective agents for inhibition of inflammatory responses in these cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19375465      PMCID: PMC2768481          DOI: 10.1016/j.neuint.2009.04.002

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  66 in total

Review 1.  Oxidative stress protection and vulnerability in aging: putative nutritional implications for intervention.

Authors:  J A Joseph; N A Denisova; D Bielinski; D R Fisher; B Shukitt-Hale
Journal:  Mech Ageing Dev       Date:  2000-07-31       Impact factor: 5.432

2.  Secretory phospholipase A2 IIA is up-regulated by TNF-alpha and IL-1alpha/beta after transient focal cerebral ischemia in rat.

Authors:  Rao Muralikrishna Adibhatla; J F Hatcher
Journal:  Brain Res       Date:  2007-01-03       Impact factor: 3.252

Review 3.  Role of redox-regulated transcription factors in inflammation, aging and age-related diseases.

Authors:  Y Lavrovsky; B Chatterjee; R A Clark; A K Roy
Journal:  Exp Gerontol       Date:  2000-08       Impact factor: 4.032

4.  Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids.

Authors:  N Leitinger; A D Watson; S Y Hama; B Ivandic; J H Qiao; J Huber; K F Faull; D S Grass; M Navab; A M Fogelman; F C de Beer; A J Lusis; J A Berliner
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-05       Impact factor: 8.311

Review 5.  Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications.

Authors:  Nurulain T Zaveri
Journal:  Life Sci       Date:  2006-01-30       Impact factor: 5.037

6.  Apocynin protects against global cerebral ischemia-reperfusion-induced oxidative stress and injury in the gerbil hippocampus.

Authors:  Qun Wang; Kenneth D Tompkins; Agnes Simonyi; Ronald J Korthuis; Albert Y Sun; Grace Y Sun
Journal:  Brain Res       Date:  2006-05-02       Impact factor: 3.252

7.  Induction of secretory phospholipase A2 in reactive astrocytes in response to transient focal cerebral ischemia in the rat brain.

Authors:  Teng-Nan Lin; Qun Wang; Agnes Simonyi; Jean-Ju Chen; Wai-Mui Cheung; Yong Y He; Jan Xu; Albert Y Sun; Chung Y Hsu; Grace Y Sun
Journal:  J Neurochem       Date:  2004-08       Impact factor: 5.372

Review 8.  Hormetic dietary phytochemicals.

Authors:  Tae Gen Son; Simonetta Camandola; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2008-06-10       Impact factor: 3.843

9.  Highly specific and broadly potent inhibitors of mammalian secreted phospholipases A2.

Authors:  Rob C Oslund; Nathan Cermak; Michael H Gelb
Journal:  J Med Chem       Date:  2008-07-08       Impact factor: 7.446

10.  Secreted phospholipase A2 type IIA as a mediator connecting innate and adaptive immunity: new role in atherosclerosis.

Authors:  Elvira Ibeas; Lucía Fuentes; Rubén Martín; Marita Hernández; Maria Luisa Nieto
Journal:  Cardiovasc Res       Date:  2008-08-28       Impact factor: 10.787

View more
  22 in total

1.  Astrocytes regulate α-secretase-cleaved soluble amyloid precursor protein secretion in neuronal cells: Involvement of group IIA secretory phospholipase A2.

Authors:  X Yang; W Sheng; D M Ridgley; M A Haidekker; G Y Sun; J C Lee
Journal:  Neuroscience       Date:  2015-05-30       Impact factor: 3.590

2.  Phytochemicals and botanical extracts regulate NF-κB and Nrf2/ARE reporter activities in DI TNC1 astrocytes.

Authors:  Deepa Ajit; Agnes Simonyi; Runting Li; Zihong Chen; Mark Hannink; Kevin L Fritsche; Valeri V Mossine; Robert E Smith; Thomas K Dobbs; Rensheng Luo; William R Folk; Zezong Gu; Dennis B Lubahn; Gary A Weisman; Grace Y Sun
Journal:  Neurochem Int       Date:  2016-05-07       Impact factor: 3.921

3.  Additive Effect of Resveratrol on Astrocyte Swelling Post-exposure to Ammonia, Ischemia and Trauma In Vitro.

Authors:  Mehran Taherian; Michael D Norenberg; Kiran S Panickar; Nagarajarao Shamaladevi; Anis Ahmad; Purbasha Rahman; Arumugam R Jayakumar
Journal:  Neurochem Res       Date:  2020-03-12       Impact factor: 3.996

4.  NGF induces the expression of group IIA secretory phospholipase A2 in PC12 cells: the newly synthesized enzyme is addressed to growing neurites.

Authors:  Vincenza Nardicchi; Monica Ferrini; Francesca Pilolli; Emanuela Biagioni Angeli; Emanuele Persichetti; Tommaso Beccari; Roberta Mannucci; Cataldo Arcuri; Rosario Donato; Robert V Dorman; Gianfrancesco Goracci
Journal:  Mol Neurobiol       Date:  2014-01-05       Impact factor: 5.590

Review 5.  Low molecular weight phospholipases A2 in mammalian brain and neural cells: roles in functions and dysfunctions.

Authors:  Gianfrancesco Goracci; Monica Ferrini; Vincenza Nardicchi
Journal:  Mol Neurobiol       Date:  2010-03-19       Impact factor: 5.590

6.  Role of polymorphic variants as genetic modulators of infection in neonatal sepsis.

Authors:  Asmaa Abu-Maziad; Kendra Schaa; Edward F Bell; John M Dagle; Margaret Cooper; Mary L Marazita; Jeffrey C Murray
Journal:  Pediatr Res       Date:  2010-10       Impact factor: 3.756

Review 7.  Phospholipases A2 and neural membrane dynamics: implications for Alzheimer's disease.

Authors:  James C-M Lee; Agnes Simonyi; Albert Y Sun; Grace Y Sun
Journal:  J Neurochem       Date:  2011-01-07       Impact factor: 5.372

Review 8.  Targeting NADPH oxidase and phospholipases A2 in Alzheimer's disease.

Authors:  Agnes Simonyi; Yan He; Wenwen Sheng; Albert Y Sun; W Gibson Wood; Gary A Weisman; Grace Y Sun
Journal:  Mol Neurobiol       Date:  2010-03-02       Impact factor: 5.590

Review 9.  Why pleiotropic interventions are needed for Alzheimer's disease.

Authors:  Sally A Frautschy; Greg M Cole
Journal:  Mol Neurobiol       Date:  2010-05-02       Impact factor: 5.590

Review 10.  Phospholipases A2 and inflammatory responses in the central nervous system.

Authors:  Grace Y Sun; Phullara B Shelat; Michael B Jensen; Yan He; Albert Y Sun; Agnes Simonyi
Journal:  Neuromolecular Med       Date:  2009-10-24       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.